Insights, thoughts, events and interesting publications about plain language summaries and communicating research to patients and non-specialist audiences
The latest plain language summary describes the findings of the ASCENT study looking at sacituzumab govitecan as a treatment for metastatic triple-negative breast cancer.
The new plain language summary in Future Oncology helps patients understand the results of the GARNET study of dostarlimab in recurrent or advanced endometrial cancer.
Discover Open Pharma’s new crib sheet explaining the different types of plain language documents.
Read the article summarising the results of two studies looking at vosoritide as a potential treatment for children with achondroplasia.
Learn how Pfizer implemented a company-wide program for developing plain language summaries to support their publications.
Read the latest supplementary plain language summary published alongside an article in Future Oncology.
Our latest plain language summary helps patients with HER2-positive breast cancer understand the results of the DESTINY-Breast01 study.
A new article discusses the lessons from the Patient-Centered Outcomes Research Institute’s (PCORI) programme developing plain language summaries of the research they have funded.
Our latest Plain Language Summary of Publication (PLSP) published in Future Microbiology.
Open Pharma have announced their recommendations for plain language summaries of peer-reviewed medical journal publications is now available as a preprint.
We are pleased to announce that our initiative for publishing standalone Plain Language Summary of Publication (PLSP) articles has been shortlisted for the ALPSP Awards for Innovation in Publishing 2021.
The editors of Journal of Geophysical Research: Solid Earth announce that plain language summaries will be required for all manuscripts.
Plain language summary of the GioTag study now published in Future Oncology.
Much awaited ‘How-To’ Guide for the development and dissemination of plain language summaries of peer-reviewed publications and conference presentations.
In their latest post “Don’t Just Produce Plain Language Summaries: Seven Tips to Get Them Read”, Deborah Wyatt and Marisha Fonseca of Impact Science at Cactus Communications share their thoughts on how to make PLS discoverable and drive readership.
Overview of the poster ‘Current state and challenges for plain-language summary development in Japan’ presented at the 17th Annual Meeting of ISMPP.
Discover the latest supplementary PLS published in Future Oncology
Summary of the poster ‘Are plain language summaries of health economic publications needed for patients and non-expert audiences?’ presented at the 17th Annual Meeting of ISMPP.
Animated video presenting the EXPLORER-HCM study plain language summary.
Written by Cynthia Burstein Waldman (a patient author) and Anjali Owens, a new PLSP ‘A plain language summary of the EXPLORER-HCM study: mavacamten for obstructive hypertrophic cardiomyopathy’ has been published in Future Cardiology.
Hosted by the CISCRP, this webinar provides a greater understanding on how Plain Language Summaries of Publication (PLSP) can help meet the demand and expectations for the disclosure of clinical trial results.
On Wednesday 5th May 2021, the Center for Information and Study on Clinical Research Participation (CISCRP) are hosting a free webinar ‘Plain Language Summaries of Publications (PLSPs): What Are They & How to Create One’ to better understand how plain language summaries of publications can help meet the demand and expectation for the disclosure of clinical trial results. With panellists from CISCRP, Future Science Group, Oxford PharmaGenesis, Bayer and Daiichi Sankyo, this multi-stakeholder event will provide the opportunity for everyone interested to learn about the practicalities of publishing PLSP. By…
In this post, Deborah Wyatt and co-author Marisha Fonseca from Impact Science at Cactus Communications, share five simple ‘hacks’ to make plain language summaries (PLS) of research papers easier to translate.
The European Medicines Agency (EMA) has recently published a new resource providing descriptions of medical terms commonly used in information about medicines written in plain language.
Two new initiatives on plain language summaries of publications are now inviting public consultation.
Summary of the poster ‘How readable are plain language summaries?’ presented at the 2021 ISMPP European Meeting.
ARAMIS study plain language summary discussed in an animated video.
The latest plain language summary of publication (PLSP) published in Future Oncology provides a summary of the ARAMIS trial.
Start as you mean to go on: why Roger Wilson advocates that all research projects should start with writing a plain language summary.
Keen to recognize and promote the vital role of patients in medical and scientific research, the Future Science Group is publishing Plain Language Summary of Publication articles. Find out more about this new initiative.
Learn about plain language summaries in the upcoming ISMPP U webinar taking place on February 3rd 2021.
The recent call to action in the MAP newsletter from the International Society for Medical Publication Professionals (ISMPP) has set out a roadmap for how medical publication and communication professionals can ensure equity, diversity, and inclusion in communicating scientific research.
Our very own Laura Dormer will be speaking at the 2021 European Meeting of ISMPP parallel session on ‘Patient Engagement in Publications: The ‘What’, ‘Who’, ‘Why’, ‘When’ and ‘How’. Taking place on Tuesday 26th January 2021, the session will look at key areas of the publication ecosystem where patients can and should be involved.
The first of it’s kind published in a peer-reviewed journal, this article published in Future Oncology provides a lay language summary of the ENLIVEN study.